期刊文献+

孕烷X受体基因多态性对肾移植受者他克莫司浓度/剂量比的影响 被引量:6

Effect of PXR gene polymorphism on concentration/dose ratios of tacrolimus in kidney transplant patients
原文传递
导出
摘要 目的研究肾移植受者的孕烷X受体(PXR)基因多态性对他克莫司浓度/剂量比的影响。方法记录患者的体重、他克莫司血药浓度等,用PCR产物直接测序法对肾移植受者进行基因分型,比较不同基因型患者间他克莫司的浓度/剂量比。结果 PXR-C24381A基因多态性与他克莫司浓度/剂量比值明显相关;他克莫司浓度/剂量比,在A/A型患者明显低于C/A型和C/C型患者(P<0.05),而PXR-A7635G基因多态性对其比值无影响(P>0.05)。结论要取得相同血药浓度,PXR-A24381A基因型患者要比PXR-C24381A型和PXR-C24381C型服用的剂量更高。 Objective To investigate the effect of PXR gene polymor- phism on the concentration/dose ratios of tacrolimus in kidney transplant patients. Methods Blood samples were collected from kidney transplant patients who received tacrolimus. The PXR genotypes were determined by the polymerase chain reaction (PCR) - direct sequencing. Tacrolimus tough concentration was measured by ELISA. The concentration/dose ratio were collected. Results PXR - C24381A gene polymorphism was significantly related with the concentration/dose ratios of patients. Patients with A/A genotype carrier was significantly lower than those with C/A genotype or C/C genotype ( P 〈 0.05 ). No difference was found among the PXR - A7635G genotypes ( P 〉 0. 05 ). Conclusion PXR - C24381A polymorphism is correlated with the whole blood concentration/ dose ratio in kidney transplant patients. genotype ; gene polymorphism
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2013年第6期446-448,共3页 The Chinese Journal of Clinical Pharmacology
基金 深圳市科技计划基金资助项目(201203053)
关键词 肾移植 他克莫司 孕烷X受体基因 基因多态性 kidney transplantation tacrolimus PXR genotype gene polymorphism
  • 相关文献

参考文献4

二级参考文献61

共引文献6

同被引文献31

  • 1Carlson CS, Eberle MA, Rieder M J, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium[J]. Am J Hum Genet, 2004, 74(1): 106-120. 被引量:1
  • 2Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry[J]. Proc Natl Acad Sci U S A, 2001, 98(2): 581-584. 被引量:1
  • 3Wang Y, Wang C, Li J, et al. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co- treated with diltiazem[J]. Eur J Clin Pharmacol, 2009, 65(3): 239-247. 被引量:1
  • 4Orans J, Teotico DG, Rcdinbo MR. The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges[J]. Mol Endocrinol, 2005, 19(12): 2891-2900. 被引量:1
  • 5Lamba J, Lamba V, Schuetz E. Genetic variants of PXR (NRII2) and CAR (NRII3) and their implications in drug metabolism and pharmacogenetics[J]. Curr Drug Metab, 2005, 6(4): 369-383. 被引量:1
  • 6Svd J, Spiers JP, Mulcahy F, et al. Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NRII2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans[J]. J Acquir Immune Defic Syndr, 2010, 55(5): 536-549. 被引量:1
  • 7Press RR, Ploeger BA, den Hartigh J, et al. Explaining variability in ciclosporin exposure in adult kidney transplant recipients[J]. Eur J Clin Pharmacol, 2010, 66(6): 579-590. 被引量:1
  • 8CHOI Y, JIANG F, AN H, et al pharmacokinetics of tacmhmus in A pharmacogenomie study on the healthy subjects using the 13MET (TM) Plus platform [J/ELI. 2016-02-1612016-05 -10]. http://www, nature, com/tpj/journalfvaop/ncurrent/fullftpj2015 99a. html. 被引量:1
  • 9BRUCKMUELLER H,WERK A N,RENDERS L,et al. Which ge- netic determinants should be considered for tacrolimus dose optimiza- tion in kidney transplantation? A combined analysis of genes affecting the CYP3A locus[J]. Ther Drug Monit, 2015,37(3) :288 -295. 被引量:1
  • 10侯明明,侯颖,宋洪涛,王庆华,杨顺良,谭建明.肾移植患者CYP3A4基因多态性对他克莫司疗效和不良反应的影响[J].中国药房,2010,21(26):2427-2429. 被引量:31

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部